Your browser doesn't support javascript.
loading
The use of clozapine is protective for low bone mineral density induced by prolactin-raising antipsychotics in inpatients with schizophrenia.
Qiu, Jing; Gong, Hongxia; Wang, Bixin; Gu, Weiguo; Wang, Lei; Gu, Miaomiao; Zhang, Yuan; Du, Xiangdong.
Afiliação
  • Qiu J; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Gong H; Department of Radiology, Wuxi Fifth People's Hospital, Wuxi, China.
  • Wang B; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Gu W; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Wang L; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Gu M; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Zhang Y; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China.
  • Du X; Department of Radiology or Clinical Medicine Center for Mental illness, Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu Province, China. duxiangdong888@126.com.
Arch Osteoporos ; 15(1): 98, 2020 06 29.
Article em En | MEDLINE | ID: mdl-32601884
Low bone mineral density (BMD) is common among patients with schizophrenia; however, the pathogenesis is still unclear. Different types of antipsychotics may have different effects on BMD in inpatients with schizophrenia. INTRODUCTION: This retrospective study aimed to evaluate the effects of prolactin-raising (PR) antipsychotics vs. clozapine combined with PR antipsychotics on BMD of patients with schizophrenia and analyzed clinically related factors that may affect BMD. METHODS: A total of 125 participants (males/females = 62/63) were included. Patients were treated with PR antipsychotics vs. clozapine combined with PR antipsychotics. They were similar in demographic and clinical characteristics. BMD was examined in their lumbar spine and proximal femur by a dual-energy X-ray (DEXA) absorption measurement device. Laboratory variables (including blood levels of prolactin, estradiol, testosterone, and cortisol) were collected. RESULTS: Among 125 inpatients with schizophrenia, the prevalence of osteoporosis and low BMD (including osteoporosis and osteopenia) was 26.4% and 64%. The average BMD T value in patients receiving clozapine combined with PR antipsychotics was significantly higher than in patients receiving PR antipsychotics (p < 0.05). Patients in the clozapine combined with PR antipsychotic group had higher testosterone levels than the PR antipsychotic group (Z = - 2.77, p = 0.006). Linear logistic regression analysis indicated that clozapine combined with PR antipsychotic treatment (p < 0.05) and higher estradiol level (p < 0.05) may be significantly associated with higher BMD. CONCLUSIONS: Our results suggest that the use of clozapine may be a protective factor for low BMD induced by PR antipsychotics in inpatients with schizophrenia. The possible mechanism is that clozapine may protect BMD by regulating estrogen and testosterone levels, but the mechanism by which clozapine regulates these two sex hormones needs further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Doenças Ósseas Metabólicas / Clozapina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Arch Osteoporos Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Doenças Ósseas Metabólicas / Clozapina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Arch Osteoporos Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China